David Molowa has joined MPM BioEquities as a general partner based in New York. He previously was with Venrock and served as a strategic advisor to Amgen. MPM BioEquities is a private fund that invests in public biotech companies and, to a lesser extent, private biotech companies. www.mpmcapital.com
Nearly there!
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case
it’s been delivered there.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.